The RADAR Study: Week 48 Safety and Efficacy of RAltegravir Combined with Boosted DARunavir Compared to Tenofovir/Emtricitabine Combined with Boosted Darunavir in Antiretroviral-Naive Patients. Impact on Bone Health-Reference-Cited by-同舟云学术

The RADAR Study: Week 48 Safety and Efficacy of RAltegravir Combined with Boosted DARunavir Compared to Tenofovir/Emtricitabine Combined with Boosted Darunavir in Antiretroviral-Naive Patients. Impact on Bone Health

Published:2014-08-29 Issue:8 Volume:9 Page:e106221
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bedimo Roger J.,Drechsler Henning,Jain Mamta,Cutrell James,Zhang Song,Li Xilong,Farukhi Irfan,Castanon Rosinda,Tebas Pablo,Maalouf Naim M.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference25 articles.

1. Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents;R Bedimo;AIDS,2012

2. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration;Lancet,2008

3. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients;AIDS,2008

4. Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy;PE Sax;N Engl J Med,2009

5. Class-sparing regimens for initial treatment of HIV-1 infection;SA Riddler;N Engl J Med,2008

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tenofovir-induced osteopenia and hyperparathyroidism: A case report and literature review;Frontiers in Endocrinology;2023-01-11

2. Two-drug regimens for HIV treatment;The Lancet HIV;2022-12

3. Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort;Infectious Diseases and Therapy;2022-04-11

4. Effectiveness and Safety Analysis of PIs/r Based Dual Therapy in Treatment-Naïve, HIV/AIDS Patients: A Network Meta Analysis of Randomized Controlled Trials;Frontiers in Pharmacology;2022-03-04

5. Risk of failure in dual therapy versus triple therapy in naïve HIV patients: a systematic review and meta-analysis;Clinical Microbiology and Infection;2021-01